| Product Information | |
|---|---|
| Composition | Mycophenolate Mofetil 500 mg |
| Dosage | Tablet |
| Packing Size | 10 x 10 |
| Packing | Alu-Alu |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
Mycocia 500 contains Mycophenolate Mofetil 500mg, an immunosuppressive medication widely used in the prevention of organ transplant rejection. It works by inhibiting the proliferation of T and B lymphocytes, thereby reducing the risk of the immune system attacking the transplanted organ.
Prevents organ rejection after kidney, heart, or liver transplantation.
Helps maintain long-term graft survival.
Provides effective immunosuppression with a well-established safety profile.
Often used in combination with other immunosuppressive agents like cyclosporine or tacrolimus.
Prophylaxis of organ rejection in renal transplant
Prophylaxis of organ rejection in cardiac transplant
Prophylaxis of organ rejection in hepatic transplant
Dosage should be taken strictly as prescribed by the transplant physician. The tablets should be swallowed whole with water, preferably on an empty stomach.
Use only under strict medical supervision.
Contraindicated in pregnancy due to potential risk of birth defects.
Patients should avoid live vaccines while on therapy.
Regular monitoring of blood counts and renal function is recommended.
Keep away from children and store in a cool, dry place.
